Avenue Therapeutics, Inc.

( )
ATXI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.55%44.190.9%$1265.49m
ABBVAbbVie, Inc. 0.85%107.311.9%$1024.22m
JNJJohnson & Johnson 0.54%164.820.7%$998.60m
MRKMerck & Co., Inc. 1.40%73.050.7%$880.20m
LLYEli Lilly & Co. 1.65%232.061.1%$598.53m
BMYBristol-Myers Squibb Co. 0.78%60.621.0%$573.53m
AZNAstraZeneca Plc 1.26%59.481.0%$335.33m
NVSNovartis AG 0.93%83.570.2%$162.07m
CRVSCorvus Pharmaceuticals, Inc. -6.14%7.030.7%$143.77m
GSKGlaxoSmithKline Plc 0.15%39.340.2%$135.46m
SNYSanofi 0.50%48.720.2%$123.92m
RGENRepligen Corp. 3.55%324.216.8%$120.88m
RPRXRoyalty Pharma Plc 2.32%37.130.1%$120.28m
VTRSViatris, Inc. 0.68%13.340.0%$108.50m
NVONovo Nordisk A/S 1.24%102.120.1%$102.45m

Company Profile

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.